New Kennedy/Eshoo Personalized Medicine Bill Tackles Hot Topics in PGx
June 02, 2010
New Kennedy/Eshoo Personalized Medicine Bill Tackles Hot Topics in PGx
Compared to previous personalized bills, HR 5440 includes much more toothy language about FDA regulatory muscle over companion tests. It would also create an Office of Personalized Healthcare to recommend which tests should be regulated and how personalized medicine products should be reimbursed, and form several committees to address translational challenges of personalized medicine.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- DTC Genomics Gets Time Before FDA as Agency Considers Regulatory Strategy
July 21, 2010 / Pharmacogenomics Reporter - Q&A: CDC's Khoury Discusses GAPPNet's Strategy to Drive Adoption of Personalized Medicine
July 15, 2009 / Pharmacogenomics Reporter - GAPPNet Launches New Evidence Review Database and Open Access Journal
June 16, 2010 / Pharmacogenomics Reporter - FDA's Gutierrez Provides Additional Clarity Regarding Oversight of DTC Genomics Firms
May 19, 2010 / Pharmacogenomics Reporter - Palmetto's Loss of Jurisdiction E Medicare Contract Raises Questions About Fate of MolDx Program
October 17, 2012 / Pharmacogenomics Reporter